For the Inventor, By the Inventor

Enter assignee name

Herlev, Denmark

Nordic Bioscience A/s

USPTO Granted Patents = 16

EPO Patents = 30

Trademarks = 1

Forward Citations = 41

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Morten A Karsdal (14 out of 26 patents)

Efstathios Vassiliadis (6 out of 6 patents)

Diana Julie Oersnes-Leeming (5 out of 5 patents)

4. Diana Julie Leeming (4 out of 5 patents)

5. Sanne S Veidal (4 out of 4 patents)

6. Natasha Barascuk Michaelsen (3 out of 5 patents)

7. Helene Skjot-Arkil (3 out of 3 patents)

8. Antonio Segovia-Silvestre (3 out of 3 patents)

9. Natasha Barascuk (3 out of 3 patents)

10. Per Qvist (2 out of 19 patents)

11. Mette Juul Nielsen (2 out of 2 patents)

12. Yi He (2 out of 2 patents)

13. Shu Sun (2 out of 2 patents)

14. Kim Henriksen (1 out of 8 patents)

15. Jacob Hull Kristensen (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 12391747 - Type XXIII collagen assay (2025-08-19),

2. 12366582 - Collagen type X alpha-1 assay (2025-07-22),

3. 11634479 - Immunoassay for collagen type VI (2023-04-25),

4. 11531028 - Collagen type X alpha-1 assay (2022-12-20),

5. 10267809 - Biochemical markers for CVD risk assessment (2019-04-23),

6. 10001490 - Biochemical markers for pulmonary and other diseases (2018-06-19),

7. 9880177 - Fibrosis biomarker assay (2018-01-30),

8. 9835631 - Combined biomarker measurement of fibrosis (2017-12-05),

9. 9726674 - PIIINP neo-epitope assay (2017-08-08),

10. 9606130 - Fibrosis biomarker assay (2017-03-28),

11. 9500659 - In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein (2016-11-22),

12. 9459260 - Detection of diagnostic peptides (2016-10-04),

13. 9404932 - Pathology biomarker assay (2016-08-02),

14. 9359633 - Biochemical markers for CVD risk assessment (2016-06-07),

15. 9206464 - Fibrosis biomarker assay (2015-12-08),

Nordic Bioscience A/S is a leading globally operating biotechnology company specializing in the discovery and development of novel biomarkers. With a strong focus on osteoporosis, osteoarthritis, and fibrosis, Nordic Bioscience conducts cutting-edge research to identify innovative solutions for personalized medicine. Their expertise lies in providing comprehensive contract research services, offering biomarker analyses, and developing new therapies to address unmet medical needs. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#4 in Herlev

#176 in Denmark

#36,685 in the World

Herlev, Denmark

Nordic Bioscience A/s

Forward Citations = 41

27 inventors:

Morten A Karsdal (14 out of 26 patents)

Efstathios Vassiliadis (6 out of 6 patents)

Diana Julie Oersnes-Leeming (5 out of 5 patents)

4. Diana Julie Leeming (4 out of 5 patents)

5. Sanne S Veidal (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…